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The healing of long bone fractures in dogs is an unsure and lengthy 
process if the bones cannot be anatomically reconstructed or if the physical 
status of the patient is less than ideal. If not assisted, the most likely result 
is a non-union. A non-union is when the fracture site heals without bone 
formation. The resulting fibrous tissue forms a pseudo j oint which moves 
when subjected to muscle forces, causing considerable pain in the patient. 
Long bone fractures are usually corrected through the use of internal or 
external fixation devices. These devices lengthen healing time and usually 
require a surgical procedure to implant or fix them in place. Delayed 
healing can also lead to muscle atrophy, j oint stiffness, and even refracture 
of the bone. 
The purpose of this project is to examine the effect of the addition of 
canine growth hormone on the healing of long bone fractures in dogs. 
Growth hormone has effects on cartilage and bone and has been proved to 
enhance fracture healing in laboratory rodents. There are also reports of its 
use in the treatment of delayed union fractures in geriatric humans. 
This experiment will investigate the effects of recombinant growth 
hormone administered via a subcutaneous implant on bone healing in a non­
rigid fracture healing model. Non-rigid refers to the fact that during the 
healing process, the ends of the fractured bones will not be fixed or splinted 
in any way. Mature dogs, which have a low growth hormone concentration 
and production compared to immature dogs, will be used. The degree of 
healing will be assessed radiographically, photodensitometrically, and 
scintigraphically. Force plate gait analysis will be used to determine the 
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functional use of the affected limb. Finally, biomechanical tests in three 
point bending will evaluate the mechanical strength of the bone healing by 
determining the stiffness and ultimate strength of the healed bone in relation 
to that of the intact radius. 
This study will provide important information about the quality and 
time of bone healing in dogs treated with exogenous growth hormone. 
Although this study will concentrate only on bone healing in dogs, valuable 
comparative data will be obtained. Future studies may be able to 
extrapolate this and other data to the study of human fracture healing. 
Motive and History 
Serious fractures of the long bones are common in dogs. Due to 
small bone fragment size or missing fragments, such fractures can not 
always be reduced or stabilized through the use of fixation devices. 
Secondary bone healing, or healing through the formation of a bony callus 
around the fracture site, occurs when there is a ga1J wider than 1 mm 
between fracture ends, or when the fracture site is non-rigid. Missing bone 
fragments can cause extraordinarily large forces to be placed on fixation 
devices. These forces coupled with the delayed healing time can cause 
premature failure of the device and can lead to refracture of the bone. 
The effects of the growth hormone somatotropin (ST) on cells of 
bone and cartilage have been investigated both in the body and in a 
laboratory environment. ST stimulates bone growth along the axis of the 
bone by stimulating the local production of insulin-like growth factor I, 
which is one of the key factors in bone repair. Most of the early studies 
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have focused on using rats with human or bovine growth hormone. Despite 
the fact that these studies used a wide range of dose levels, length of 
treatment, and source, nearly all of them showed a stimulatory effect on 
bone healing in patients subj ected to growth hormone. 
To date no complete studies have focused on the influence of canine 
growth hormone on the radiographic, scintigraphic, functional, and 
biomechanical aspects of the healing of long bone fractures in dogs. A 
radial ostectomy, or the removal of a piece of the front limb bone known as 
the radius, will allow the evaluation of fracture healing in a non-rigid model 
while mini zing patient discomfort. The discomfort of the patient will be 
minimized by leaving the ulna, next to the radius, intact and allowing the 
weight of the animal to be shared by the intact bone. 
Radiographic changes are one of the most widely used indicators 
used to assess fracture healing. Radiographic analysis is done by injecting a 
harmless radioactive isotope into the animal at the fracture site. This 
isotope is taken up by the tissue surrounding the site and when examined 
through a device which allows the viewing of the isotope, a picture of the 
healing site can be generated. Photodensitometry provides a more accurate 
estimate of bone mineral content by comparing the absorbance of light 
through a point on the radiograph to the absorbance through a standard 
medium. 
Nuclear scintigraphy is a good indicator of the level of bone cell and 
vascular activity. Technetium 99 is a commonly used radionucleide 
because its uptake correlates well with active bone metabolism as well as 
capillary budding. During fracture healing, capillaries bud into the fracture 
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site and provide extra nutrients to the osteoblastic, or bone producing, cells. 
Growth hormone has a positive effect on capillary budding. The use of 
growth hormone may increase the amount of budding taking place in the 
fracture and increase the level of bone production, hence speeding the 
healing process. 
Weightbearing by the injured limb can provide effective information 
about the functional use of the fracture during healing. Force plate gait 
analysis provides information regarding the vertical, horizontal, breaking, 
and propulsive forces placed on the injured limb. Because one of the goals 
of this study is to decrease the healing time and return the patient to full use 
of the fractured limb as soon as possible, this information is vital to the 
assessment of the quality of the bone healing. If the growth hormone has a 
positive effect on the healing time, the dogs treated with it should place 
more weight on the injured limb sooner than the untreated dogs. 
Biomechanical testing will provide data regarding the actual strength 
and stiffness of the bone after fracture healing. A load vs. diaplacement 
curve is generated when the bones are tested in three point bending as 




figure 1: Example of three point bending 
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figure 2: Sample load vs. displacement curve 
To account for physical variations among the dogs, the biomechanical 
information from the fractured radius will be compared to the data for the 
intact radius for each dog. 
Materials and Methods 
Eight healthy, mature, female beagle dogs weighing between 20 and 
25 lb were allocated into two groups of four. The dogs then underwent a 
radial ostectomy of a random radius. A 3 mm section of the radius was 
removed from one radius of each dog. One group of dogs received 
somatotropin growth hormone via a subcutaneous implant during healing 
while the other control group received a saline placebo. The implants 
release 4 mg of somatotropin per day for 42 days. These implants were a 
gift from the Monsanto Company (Dr. Frances Buonomo). The dogs were 
kept at a relatively constant weight level throughout the study. They were 
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allowed unrestrained movement during healing to promote the non-rigid 
fracture model. 
Radiographic Evaluation 
Dogs were sedated with acepromazine (.05 mg/lb) and butorphanol 
(.1 mg/lb). Radiographs from the lateral and front views were taken prior to 
surgery, immediately following surgery, and at 2, 4, 6, and 8 weeks during 
the course of the project. A standard aluminum stepwedge was placed on 
the radiograph to provide radiographic density controls for 
photodensitometric scanning. 
Fracture healing was assessed blindly by a board certified veterinary 
radiologist (Dr. Greg Daniel). Healing was assessed by examining the 
callus formation, cellular reaction, and gap distance between bone ends. 
Photo densitometric measurements were taken to determine the bone 
density. 
Nuclear Scintigraphy 
While the dogs are sedated for the radiographic tests, nuclear scans of 
the fractured radius were made. These scans were also performed prior to 
surgery as well as 2, 4, 6, and 8 weeks during the course of the study. 
Scans were run by administering 20 me of 99Technitium methylene 
diphosphonate by intravenous injection. Two hours following injection, a 
large field gamma camera was used to produce images of the healing bone. 
Each picture was assessed by Dr. Greg Daniel to evaluate isotope 
accumulation at the fracture site in relation to the normal adjacent bone. 
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Uptake of the iosotope in the fractured limb was compared to that of the 
intact limb. 
Force Plate Gait Analysis 
An AMTI Model OR6-6 force plate was used to obtain information 
on the functional use of the injured limb. Tests were run prior to surgery 
and at 2, 4, 6, and 8 weeks after surgery. The dogs were were trotted across 
the plate at velocities from 2.1 to 2.4 m/s for three trials for each dog. 
Through this test, the peak vertical force, breaking force, and propulsive 
forces were measured. 
Biomechanical Testing 
At the end of the eight week testing period, the dogs were euthanized 
and both the intact and fractured radii from each dog were surgically 
removed. The bones were then radiographed and then subjected to three 
point bending tests performed on an Instron testing machine. A downward 
deflection was applied at 2 mm/min until failure of the specimen was 
achieved. A load vs. displacement curve was generated for each tested 
bone. From these curves, the stiffness (elastic modulus), ultimate strength, 





Radiographs of the dogs treated with somatotropin showed increased 
fracture healing. There was a great deal of callus formation and nearly 
reached union at the end of the 8 week period. Untreated dogs had little 
callus formation and slow fracture healing. The bones were progressing to 
non-union. Charts 1-3 show the total length, thickness and amount of callus 
measured for the treated vs. untreated dogs. 
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chart 3: Total bone callus measured 
The total length, thickness, and amount of the callus was nearly 3 times 




Nuclear Scintigraphic Results 
All dogs showed increased 99Tc absroption at the fracture sites. Some 
remodeling was noticed in the ulnas due to the increased force placed on 
them during weight bearing. The somatotropin treated dogs showed a 
single active region at the fracture site while the untreated dogs maintained 
2 separate regions. 
Through ostectomy analysis, the bone and muscle density ratios for 
the dogs were calculated. The bone ratio of the humerus was 30% greater 
at 2 weeks in the treated dogs. This increase persisted throughout the study. 
The muscle count density ratio was the same for 4 weeks, but by 6 and 8 
weeks, the ratios were 90% and 60% greater in treated dogs, respectively. 
Charts 4 and 5 show these results graphically. Chart 6 shows the 
comparisons of the bone area, mineral content, and bone mineral densities 
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chart 6: Bone comarisons at fracture site 
The area, bone mineral content, and bone mineral density of the healing 
fracture site were 2.5, 5, and 2 times greater, respectively, in dogs treated 
with somatotropin than in untreated dogs. 
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Biomechanical Results 
The three point bending tests yielded the ultimate strength and 
stiffness of the intact and fractured radii. The fractured radii of dogs treated 
with somatotropin were 3 times stronger than fractured radii of untreated 
dogs (chart 7). The somatotropin did not have an effect on the unfractured 
contralateral radii (chart 8). Fractured radii of dogs treated with 
somatotropin were 5-6 times stiffer than fractured radii of untreated dogs 
(chart 9). Once again, the somatotropin did not have an effect on the 




































chart 8: Ultimate strength of intact radius 
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chart 10: Stiffness of intact radii 
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Conclusion 
The addition of somatotropin has a profound positive effect on the 
healing of fractures in dogs. The radiographs all showed increased bone 
callus and bone density in the treated dogs vs. the untreated dogs. The 
fracture site showed a unified active site under scintigraphic analysis for the 
treated dogs. This means that the fracture was progressing to a bony union. 
The untreated dogs maintained two distinct active sites at the point of 
fracture, meaning that the bone was progressing to a nonunion. 
The ultimate test of fracture healing is the strength of the bone under 
load bearing. Strength and stiffness of bone can be related to the total 
volume of bone, the bone mineral content present, and the density of the 
bone. In all of the treated dogs, the ultimate strength was about 3 larger and 
the stiffness was 5 to 6 times larger than those of the untreaded dogs. 
Future Studies 
Future studies should be run to provide other necessary information 
about the use of somatotropin for fracture healing. Valuable informantion 
should include finding an optimal dose level and method of administration 
of the hormone. Physiological repercussions such as systemic short term 
and long term effects may be studied as well. Other fracture models besides 
non-rigid should be examined. Finally, clinical studies should also be 
pursued. 
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